Hospira Vinorelbine Tartrate 50 mg/5 mL Injection vial

Država: Avstralija

Jezik: angleščina

Source: Department of Health (Therapeutic Goods Administration)

Aktivna sestavina:

vinorelbine tartrate, Quantity: 13.85 mg/mL

Dostopno od:

Hospira Australia Pty Ltd

INN (mednarodno ime):

Vinorelbine tartrate

Farmacevtska oblika:

Injection

Sestava:

Excipient Ingredients: water for injections

Pot uporabe:

Intravenous

Enote v paketu:

1 X 5 mL

Razred:

Medicine Listed (Export Only)

Tip zastaranja:

Not scheduled. Not considered by committee

Terapevtske indikacije:

Vinorelbine is indicated as a single agent or in combination with cisplatin for the first-line treatment of ambulatory patients with unresectable, advanced nonsmall cell lung cancer (NSCLC). In patients with Stage IV NSCLC, Vinorelbine is indicated as a single agent or in combination with cisplatin. In Stage III NSCLC, Vinorelbine is indicated in combination with cisplatin.

Povzetek izdelek:

Visual Identification: A clear, colourless to pale yellow solution & free from visible particulates; Container Type: Vial; Container Life Time: 2 Years; Container Temperature: Store at 2 to 8 degrees Celsius

Status dovoljenje:

Licence status A

Datum dovoljenje:

2008-05-21